scispace - formally typeset
M

Martine Extermann

Researcher at University of South Florida

Publications -  188
Citations -  14482

Martine Extermann is an academic researcher from University of South Florida. The author has contributed to research in topics: Cancer & Geriatric oncology. The author has an hindex of 52, co-authored 162 publications receiving 12660 citations. Previous affiliations of Martine Extermann include Moffitt Cancer Center.

Papers
More filters
Journal ArticleDOI

Comprehensive Geriatric Assessment and Its Clinical Impact in Oncology

TL;DR: The sum of these intervention studies suggests that a CGA can be performed in a variety of settings, is a multidisciplinary effort, and can lead to interventions that may decrease the risk of morbidity and mortality in older patients with cancer.
Journal ArticleDOI

Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?

TL;DR: The preferential over-expression of IR in the peri-tumoral microvessels suggests that hyperinsulinemia might contribute to colorectal cancer growth by enhancing angiogenesis.
Journal ArticleDOI

Cancer in nonagenarians: profile, treatments and outcomes.

TL;DR: Nonagenarians who were aged 90 or older at the time of treatment/evaluation were reviewed, and those treated for an active cancer (n=177) were included in the analysis, finding a broad range of treatments with low treatment related mortality.
Journal ArticleDOI

Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients.

TL;DR: Quantification of skeletal muscle using computed tomography (CT) is accessible using cancer patients' standard oncologic images, and the impact of this on lung functional parameters is not characterized in adult allogeneic haematopoietic stem cell transplant (alloHCT) recipients.
Journal ArticleDOI

Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study.

TL;DR: The National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE) and adjustment rules after severe toxicity are derived by consensus, but to the authors’ knowledge little is known regarding the determinants of toxicity recurrence, especially in the elderly.